search
Back to results

Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS) (COSMICS)

Primary Purpose

Cardiac Disease, Cognitive Dysfunction

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) and protocol-based interventions
Sponsored by
Instituto Nacional de Cardiologia de Laranjeiras
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Disease focused on measuring Intraoperative Neurophysiologic Monitorings

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 60 or older
  • Elective coronary artery bypass graft surgery using cardiopulmonary bypass
  • Preoperative cognitive assessment by means of Mini-Mental State Examination (MMSE) test, greater than or equal to 24
  • Signed informed consent

Exclusion Criteria:

  • Patients with focal neurologic deficit
  • Carotid artery stenosis greater than 70%
  • Patients with pre-existing cognitive dysfunction
  • Patients with psychotic disorders
  • History of allergy to adhesive part of the electrode
  • History of craniofacial surgery

Sites / Locations

  • Instituto Nacional de CardiologiaRecruiting
  • Hospital São JoséRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Cerebral Oxymetry Monitoring

Control Group

Arm Description

The following procedures should be performed sequentially in the event of cerebral desaturation after 30 seconds: The positioning of the head, the presence of facial plethora, and bad position of catheters should be corrected; In case of arterial hypotension, the causal factors should be assessed and treated; In the presence of arterial hypoxemia, the causal factors should be assessed and treated to maintain a PaO2 > 150 mmHg; In the presence of hypercapnia, adjust the ventilation parameters avoiding hyperventilation; In the presence of anemia, the causal factors should be assessed, and the decision to undergo transfusion should also take into consideration the presence of tissue hypoperfusion; In cases of SvO2 below 70% and signs of hemodynamic instability, optimize fluid replacement and ventricular global contractility; Assess the increase of brain consumption of O2, avoiding the superficial level of anesthesia, hyperthermia, and tremors.

Patients will be treated according to the attending anesthesiologist, without the monitoring of cerebral oximetry, but to maintain a heart rate between 70 - 100 bpm, lactate levels <3 mmol/L and urine output> 0.5mL/Kg/h. In case of arterial hypotension the causal factors should be assessed and treated; in case of SvO2 below 70% and signs of hemodynamic instability, optimize volume replacement and global ventricular contractility through inotropic agents (epinephrine, dobutamine or milrinone); in the presence of anemia (Hb <6 to 7g/dL during CPB or Hb <8g/dL in the pre-CPB or post-CPB period), the causal factors should be assessed and the decision to transfuse should also take into account the presence of hypoperfusion tissue (increased lactate, low SvO2, acidosis); in episodes of bradycardia with hemodynamic instability, atropine may be used.

Outcomes

Primary Outcome Measures

Preoperative cognitive function
Mini Mental State Examination (MMSE)
Postoperative cognitive dysfunction - delayed cognitive recovery
Mini Mental State Examination (MMSE)
Postoperative cognitive dysfunction - neurocognitive disorder
Mini Mental State Examination (MMSE)
Preoperative cognitive function II
Montreal Cognitive Assessment (MoCA) test
Postoperative cognitive dysfunction - delayed cognitive recovery II
Montreal Cognitive Assessment (MoCA) test
Postoperative cognitive dysfunction - neurocognitive disorder II
Montreal Cognitive Assessment (MoCA) test
Preoperative cognitive function III
The Telephone Interview for Cognitive Status (TICS)
Postoperative cognitive dysfunction - delayed cognitive recovery III
The Telephone Interview for Cognitive Status (TICS)
Postoperative cognitive dysfunction - neurocognitive disorder III
The Telephone Interview for Cognitive Status (TICS)

Secondary Outcome Measures

Incidence of postoperative delirium
Delirium will be assessed postoperatively for seven days or until discharge
Neurological injury type I (stroke)
The incidence of neurological injury type I will be evaluated for 30 days
Duration of mechanical ventilation
The duration of mechanical ventilation will be evaluated
Length of stay at the intensive care unit (ICU)
The length of stay at the intensive care unit (ICU) will be evaluated
Length of stay at the hospital
The length of stay at the hospital will be evaluated
Incidence of mortality resulting from all causes
All causes of mortality will be assessed for 30 days

Full Information

First Posted
February 16, 2021
Last Updated
August 25, 2021
Sponsor
Instituto Nacional de Cardiologia de Laranjeiras
search

1. Study Identification

Unique Protocol Identification Number
NCT04766554
Brief Title
Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS)
Acronym
COSMICS
Official Title
A Multicenter, Randomized, Controlled Clinical Trial of Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 19, 2021 (Actual)
Primary Completion Date
June 20, 2022 (Anticipated)
Study Completion Date
June 20, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instituto Nacional de Cardiologia de Laranjeiras

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Neurological dysfunction continues to be one of the complications of considerable concern in patients undergoing cardiac surgery. It was previously reported in the literature, that cerebral oxygen desaturation during cardiac surgery was associated with an increased incidence of cognitive impairment. This study aims to determine whether continuous monitoring of cerebral oximetry improves the neurocognitive outcome in coronary artery bypass surgery when associated with predetermined intervention protocol to optimize cerebral oxygenation.
Detailed Description
Despite all the progress over the last decades regarding the improvement of the perioperative care of patients with heart disease and the development of new surgical techniques, neurological dysfunction continues to be one of the complications of the greatest concern in patients undergoing cardiac surgery with cardiopulmonary bypass. Brain injury can manifest itself through permanent or temporary injury, contributing to the increase in-hospital mortality, in the length of stay in intensive care, in the length of hospital stay, to a higher incidence of motor dysfunction requiring rehabilitation, and consequently, to reduced quality of life. Even though the causes of brain injury are multifactorial, perioperative cerebral hypoperfusion, tissue hypoxia, and thromboembolic events are among the main factors related to neurological dysfunction. Several clinical studies have indicated an association between cerebral desaturation and the increase of neurological complications. Cerebral oximetry monitoring using near-infrared spectroscopy (NIRS) is a non-invasive technique used to estimate regional cerebral oxygen saturation (rSO2) and has been associated with diminishing the incidence of neurological complications. There is no consensus in the literature about its real benefit, mainly due to the absence of well-designed scientific studies that demonstrate that cerebral desaturation associated with intervention measures to improve rSO2, are related to the prevention of neurological dysfunction in adult cardiac surgery. The study hypothesis evaluates whether continuous monitoring of cerebral oximetry improves the neurocognitive outcome in coronary artery bypass surgery when associated with early interventions to optimize rSO2.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Disease, Cognitive Dysfunction
Keywords
Intraoperative Neurophysiologic Monitorings

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be monitored with cerebral oximetry using INVOS 5100 monitor (Covidien, Boulder, CO), with electrodes applied bilaterally in the frontal region. Following the placement of the electrodes, the baseline records HR, blood pressure, rSO2, and peripheral O2 saturation (SPO2) will be recorded following 1 minute of electrode placement and the proper verification of the signal on the monitor. Later, during the surgery, if the rSO2 reaches levels below 15% of the baseline values or below 50% in absolute value for over 30 seconds, protocol-based interventions will be performed in the intervention group to return the oximeter to baseline values. The alarm on the equipment should be programmed to signal values below 15% of the baseline values.
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Patients will be masked concerning the allocation group. The anesthesiologist responsible for conducting the case will not be involved in the application of the neurocognitive tests, nor will he be aware of the test results. Investigators who apply the tests will be covered up by the patient allocation group.
Allocation
Randomized
Enrollment
452 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cerebral Oxymetry Monitoring
Arm Type
Active Comparator
Arm Description
The following procedures should be performed sequentially in the event of cerebral desaturation after 30 seconds: The positioning of the head, the presence of facial plethora, and bad position of catheters should be corrected; In case of arterial hypotension, the causal factors should be assessed and treated; In the presence of arterial hypoxemia, the causal factors should be assessed and treated to maintain a PaO2 > 150 mmHg; In the presence of hypercapnia, adjust the ventilation parameters avoiding hyperventilation; In the presence of anemia, the causal factors should be assessed, and the decision to undergo transfusion should also take into consideration the presence of tissue hypoperfusion; In cases of SvO2 below 70% and signs of hemodynamic instability, optimize fluid replacement and ventricular global contractility; Assess the increase of brain consumption of O2, avoiding the superficial level of anesthesia, hyperthermia, and tremors.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Patients will be treated according to the attending anesthesiologist, without the monitoring of cerebral oximetry, but to maintain a heart rate between 70 - 100 bpm, lactate levels <3 mmol/L and urine output> 0.5mL/Kg/h. In case of arterial hypotension the causal factors should be assessed and treated; in case of SvO2 below 70% and signs of hemodynamic instability, optimize volume replacement and global ventricular contractility through inotropic agents (epinephrine, dobutamine or milrinone); in the presence of anemia (Hb <6 to 7g/dL during CPB or Hb <8g/dL in the pre-CPB or post-CPB period), the causal factors should be assessed and the decision to transfuse should also take into account the presence of hypoperfusion tissue (increased lactate, low SvO2, acidosis); in episodes of bradycardia with hemodynamic instability, atropine may be used.
Intervention Type
Device
Intervention Name(s)
Cerebral oximetry monitor (The INVOS® Cerebral/Somatic Oximeter) and protocol-based interventions
Intervention Description
In the intervention group, an alarm threshold below 15% of the baseline rSO2 value will be established. Based on the predetermined algorithm the rSO2 will be maintained at or above 85% of the baseline measurements. If the rSO2 reaches levels below 15% of the baseline values or below 50% in absolute value for over 30 seconds, protocol-based interventions will be performed to restore rSO2 to baseline levels.
Primary Outcome Measure Information:
Title
Preoperative cognitive function
Description
Mini Mental State Examination (MMSE)
Time Frame
Pre-surgery (within 10 days before)
Title
Postoperative cognitive dysfunction - delayed cognitive recovery
Description
Mini Mental State Examination (MMSE)
Time Frame
Post-surgery (7 days after surgery)
Title
Postoperative cognitive dysfunction - neurocognitive disorder
Description
Mini Mental State Examination (MMSE)
Time Frame
Post-surgery (90 days after surgery)
Title
Preoperative cognitive function II
Description
Montreal Cognitive Assessment (MoCA) test
Time Frame
Pre-surgery (within 10 days before)
Title
Postoperative cognitive dysfunction - delayed cognitive recovery II
Description
Montreal Cognitive Assessment (MoCA) test
Time Frame
Post-surgery (7 days after surgery)
Title
Postoperative cognitive dysfunction - neurocognitive disorder II
Description
Montreal Cognitive Assessment (MoCA) test
Time Frame
Post-surgery (90 days after surgery)
Title
Preoperative cognitive function III
Description
The Telephone Interview for Cognitive Status (TICS)
Time Frame
Pre-surgery (within 10 days before)
Title
Postoperative cognitive dysfunction - delayed cognitive recovery III
Description
The Telephone Interview for Cognitive Status (TICS)
Time Frame
Post-surgery (7 days after surgery)
Title
Postoperative cognitive dysfunction - neurocognitive disorder III
Description
The Telephone Interview for Cognitive Status (TICS)
Time Frame
Post-surgery (90 days after surgery)
Secondary Outcome Measure Information:
Title
Incidence of postoperative delirium
Description
Delirium will be assessed postoperatively for seven days or until discharge
Time Frame
Delirium assessment CAM-ICU preoperatively (baseline) and postoperatively twice a day during the first seven days or until discharge
Title
Neurological injury type I (stroke)
Description
The incidence of neurological injury type I will be evaluated for 30 days
Time Frame
Post-surgery (until 30 days after surgery)
Title
Duration of mechanical ventilation
Description
The duration of mechanical ventilation will be evaluated
Time Frame
Post-surgery (until 30 days after surgery)
Title
Length of stay at the intensive care unit (ICU)
Description
The length of stay at the intensive care unit (ICU) will be evaluated
Time Frame
Post-surgery (until 30 days after surgery)
Title
Length of stay at the hospital
Description
The length of stay at the hospital will be evaluated
Time Frame
Post-surgery (until 30 days after surgery)
Title
Incidence of mortality resulting from all causes
Description
All causes of mortality will be assessed for 30 days
Time Frame
Post-surgery (until 30 days after surgery)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 60 or older Elective coronary artery bypass graft surgery using cardiopulmonary bypass Preoperative cognitive assessment by means of Mini-Mental State Examination (MMSE) test, greater than or equal to 24 Signed informed consent Exclusion Criteria: Patients with focal neurologic deficit Carotid artery stenosis greater than 70% Patients with pre-existing cognitive dysfunction Patients with psychotic disorders History of allergy to adhesive part of the electrode History of craniofacial surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Carlos Galhardo, MD
Phone
+55(21)999115844
Email
cgalhardo@uol.com.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlos Galhardo, MD
Organizational Affiliation
Instituto Nacional de Cardiologia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Instituto Nacional de Cardiologia
City
Rio de Janeiro
State/Province
RJ
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carlos Galhardo, MD
Facility Name
Hospital São José
City
Criciúma
State/Province
SC
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eric Lineburger, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23267000
Citation
Zheng F, Sheinberg R, Yee MS, Ono M, Zheng Y, Hogue CW. Cerebral near-infrared spectroscopy monitoring and neurologic outcomes in adult cardiac surgery patients: a systematic review. Anesth Analg. 2013 Mar;116(3):663-76. doi: 10.1213/ANE.0b013e318277a255. Epub 2012 Dec 24.
Results Reference
result
PubMed Identifier
26808629
Citation
Deschamps A, Hall R, Grocott H, Mazer CD, Choi PT, Turgeon AF, de Medicis E, Bussieres JS, Hudson C, Syed S, Seal D, Herd S, Lambert J, Denault A, Deschamps A, Mutch A, Turgeon A, Denault A, Todd A, Jerath A, Fayad A, Finnegan B, Kent B, Kennedy B, Cuthbertson BH, Kavanagh B, Warriner B, MacAdams C, Lehmann C, Fudorow C, Hudson C, McCartney C, McIsaac D, Dubois D, Campbell D, Mazer D, Neilpovitz D, Rosen D, Cheng D, Drapeau D, Dillane D, Tran D, Mckeen D, Wijeysundera D, Jacobsohn E, Couture E, de Medicis E, Alam F, Abdallah F, Ralley FE, Chung F, Lellouche F, Dobson G, Germain G, Djaiani G, Gilron I, Hare G, Bryson G, Clarke H, McDonald H, Roman-Smith H, Grocott H, Yang H, Douketis J, Paul J, Beaubien J, Bussieres J, Pridham J, Armstrong JN, Parlow J, Murkin J, Gamble J, Duttchen K, Karkouti K, Turner K, Baghirzada L, Szabo L, Lalu M, Wasowicz M, Bautista M, Jacka M, Murphy M, Schmidt M, Verret M, Perrault MA, Beaudet N, Buckley N, Choi P, MacDougall P, Jones P, Drolet P, Beaulieu P, Taneja R, Martin R, Hall R, George R, Chun R, McMullen S, Beattie S, Sampson S, Choi S, Kowalski S, McCluskey S, Syed S, Boet S, Ramsay T, Saha T, Mutter T, Chowdhury T, Uppal V, Mckay W; Canadian Perioperative Anesthesia Clinical Trials Group. Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology. 2016 Apr;124(4):826-36. doi: 10.1097/ALN.0000000000001029.
Results Reference
result
PubMed Identifier
19101265
Citation
Slater JP, Guarino T, Stack J, Vinod K, Bustami RT, Brown JM 3rd, Rodriguez AL, Magovern CJ, Zaubler T, Freundlich K, Parr GV. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009 Jan;87(1):36-44; discussion 44-5. doi: 10.1016/j.athoracsur.2008.08.070.
Results Reference
result
PubMed Identifier
28940368
Citation
Lei L, Katznelson R, Fedorko L, Carroll J, Poonawala H, Machina M, Styra R, Rao V, Djaiani G. Cerebral oximetry and postoperative delirium after cardiac surgery: a randomised, controlled trial. Anaesthesia. 2017 Dec;72(12):1456-1466. doi: 10.1111/anae.14056. Epub 2017 Sep 22.
Results Reference
result
PubMed Identifier
24810757
Citation
Colak Z, Borojevic M, Bogovic A, Ivancan V, Biocina B, Majeric-Kogler V. Influence of intraoperative cerebral oximetry monitoring on neurocognitive function after coronary artery bypass surgery: a randomized, prospective study. Eur J Cardiothorac Surg. 2015 Mar;47(3):447-54. doi: 10.1093/ejcts/ezu193. Epub 2014 May 7.
Results Reference
result
PubMed Identifier
28882917
Citation
Serraino GF, Murphy GJ. Effects of cerebral near-infrared spectroscopy on the outcome of patients undergoing cardiac surgery: a systematic review of randomised trials. BMJ Open. 2017 Sep 7;7(9):e016613. doi: 10.1136/bmjopen-2017-016613.
Results Reference
result
PubMed Identifier
17179242
Citation
Murkin JM, Adams SJ, Novick RJ, Quantz M, Bainbridge D, Iglesias I, Cleland A, Schaefer B, Irwin B, Fox S. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007 Jan;104(1):51-8. doi: 10.1213/01.ane.0000246814.29362.f4.
Results Reference
result

Learn more about this trial

Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS)

We'll reach out to this number within 24 hrs